| #32 |
Jeewan Thakur |
Novartis Ag |
2 |
| #32 |
Judith A. Hay |
Pepperdata |
2 |
| #32 |
Lars Krapf |
Adobe |
2 |
| #32 |
Anne Kessler |
Dsm Ip Assets B.V. |
2 |
| #32 |
Marie-Christine Wolf |
Array Biopharma |
2 |
| #32 |
Christian Schutze |
Endress+Hauser Flowtec Ag |
2 |
| #32 |
Achim Schlapbach |
Novartis Ag |
2 |
| #32 |
Luke Green |
Hoffmann-La Roche |
2 |
| #32 |
Daniel Andreas Niederer |
Array Biopharma |
2 |
| #32 |
Nicole Buschmann |
Novartis Ag |
2 |
| #32 |
Florian Dalla Torre |
Straumann Holding Ag |
2 |
| #32 |
Hilmar Erhard Ebersbach |
Novartis Ag |
2 |
| #32 |
Hans Jürg Kirner |
Basf Se |
2 |
| #32 |
Katharina Misteli |
Basf Se |
2 |
| #32 |
Alexander Lederer |
Polyphor Ag |
2 |
| #32 |
Alexander Baxter Smith |
Novartis Ag |
2 |
| #32 |
Frank Schaefer |
Robert Bosch Gmbh |
2 |
| #32 |
Lothar Lindemann |
Hoffmann-La Roche |
2 |
| #32 |
Ruediger Wilz |
Kpss-Kao Professional Salon Services Gmbh |
2 |
| #32 |
Alexandra Teleki |
Dsm Ip Assets B.V. |
2 |
| #32 |
Nikolay A. GRIGORENKO |
Basf Se |
2 |
| #32 |
Christophe Folly |
Evolva Sa |
2 |
| #32 |
Edoardo Menozzi |
Basf Se |
2 |
| #32 |
Marian Misun |
Array Biopharma |
2 |
| #32 |
Bernhard Helk |
MIT |
2 |
| #32 |
Nityakalyani Srinivas |
Polyphor Ag |
2 |
| #32 |
Hanno R. Van der Wal |
Dow Global Technologies |
2 |
| #32 |
Christoph Max Krell |
Novartis Ag |
2 |
| #32 |
Glenn E. Dale |
Bioversys Ag |
2 |
| #32 |
Philipp Brun |
Depuy Synthes Products |
2 |
| #32 |
Wolfgang Holzgreve |
Sequenom |
2 |
| #82 |
Peter Grutter |
Rolic Ag |
1 |
| #82 |
Josephine JUETTNER |
Friedrich Miescher Institute For Biomedical Research |
1 |
| #82 |
Sophie Laurenson |
Abbott |
1 |
| #82 |
Markus Weiss |
Novartis Ag |
1 |
| #82 |
Cristina Lopez-Lopez |
Novartis Ag |
1 |
| #82 |
Christian GSTOETTMAYR |
Dsm Ip Assets B.V. |
1 |
| #82 |
Szilvia MESAROS |
Dsm Ip Assets B.V. |
1 |
| #82 |
Sarah Hopper |
Syngenta Participations Ag |
1 |
| #82 |
Johannes Singler |
— |
1 |
| #82 |
Stefan Reinelt |
Basilea Pharmaceutica Ag |
1 |
| #82 |
Phillippe Lindenmann |
Depuy Synthes Products |
1 |
| #82 |
Pierre Elemans |
Dsm Ip Assets B.V. |
1 |
| #82 |
Christiane Maier |
Dsm Ip Assets B.V. |
1 |
| #82 |
Miloud Achour |
Novartis Ag |
1 |
| #82 |
Florence Tixeront |
Hoffmann-La Roche |
1 |
| #82 |
Joanna Norström |
Medartis Ag |
1 |
| #82 |
Caspar Vogel |
Novartis Ag |
1 |
| #82 |
Helen Hachemi |
Covagen Ag |
1 |
| #82 |
Dietmar Hueglin |
Basf Se |
1 |